Back to Search Start Over

PPARα/RXRα downregulates amino acid catabolism in the liver via interaction with HNF4α promoting its proteasomal degradation.

Authors :
Tobón-Cornejo S
Vargas-Castillo A
Leyva-Martínez A
Ortíz V
Noriega LG
Velázquez-Villegas LA
Aleman G
Furosawa-Carballeda J
Torres N
Tovar AR
Source :
Metabolism: clinical and experimental [Metabolism] 2021 Mar; Vol. 116, pp. 154705. Date of Electronic Publication: 2021 Jan 07.
Publication Year :
2021

Abstract

The preservation of body proteins is essential to guarantee their functions in organisms. Therefore, the utilization of amino acids as energy substrates is regulated by a precise fine-tuned mechanism. Recent evidence suggests that the transcription factors peroxisome proliferator-activated receptor alpha (PPARα) and hepatocyte nuclear factor 4 alpha (HNF4α) are involved in this regulatory mechanism. Thus, the aim of this study was to determine how these transcription factors interact to regulate the expression of amino acid catabolism genes. In vivo studies using PPARα-knockout mice (Pparα-null) fed different amounts of dietary protein showed that in the absence of PPARα, there was a significant increase in HNF4α abundance in the liver, which corresponded with an increase in amino acid catabolizing enzyme (AACE) expression and the generation of increased amounts of postprandial urea. Moreover, this effect was proportional to the increase in dietary protein consumed. Chromatin immunoprecipitation assays showed that HNF4α can bind to the promoter of AACE serine dehydratase (SDS), an effect that was potentiated by dietary protein in the Pparα-null mice. The mechanistic studies revealed that the presence of retinoid X receptor alpha (RXRα) is essential to repress HNF4α activity in the presence of PPARα, and this interaction accelerates HNF4α degradation via the proteasome pathway. These results showed that PPARα can downregulate liver amino acid catabolism in the presence of RXRα by inhibiting HNF4α activity.<br />Competing Interests: Declaration of competing interest None.<br /> (Copyright © 2021 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1532-8600
Volume :
116
Database :
MEDLINE
Journal :
Metabolism: clinical and experimental
Publication Type :
Academic Journal
Accession number :
33422545
Full Text :
https://doi.org/10.1016/j.metabol.2021.154705